Description

Clabax OD (clarіthromycin) tablets with prolonged release 500 mg. №5

Ingredients

Active ingredient: Clarithromycin 500 mg.
Other ingredients: Cellulose, hypromellose, lactose, magnesium stearate, povidone, talc, titanium dioxide, and more.

Dosage

Recommended dosage: One tablet once daily.
Swallow the tablet whole with a full glass of water. Do not crush or chew the tablet.

Indications

Clabax OD tablets are indicated for the treatment of bacterial infections caused by susceptible microorganisms, including respiratory tract infections, skin and soft tissue infections, and more.

Contraindications

Do not use Clabax OD tablets if:

• You are allergic to clarithromycin or any other macrolide antibiotics.
• You are taking colchicine in patients with renal or hepatic impairment.
• You are using certain medications like ergotamine or dihydroergotamine.

Directions

Take Clabax OD tablets exactly as prescribed by your healthcare provider. Follow all instructions on the prescription label. Do not take this medicine in larger or smaller amounts or for longer than recommended.

Scientific Evidence

Clarithromycin, the active ingredient in Clabax OD tablets, has been extensively studied for its efficacy in treating various bacterial infections. Research published in the International Journal of Antimicrobial Agents has shown clarithromycin to be effective against a wide range of pathogens, making it a valuable option in the management of respiratory and skin infections.

Additional Information

It is important to complete the full course of treatment with Clabax OD tablets as prescribed by your healthcare provider, even if you start to feel better before the medication is finished. Stopping the medication prematurely can lead to the development of antibiotic resistance.

Clarithromycin, the active ingredient in Clabax OD tablets, belongs to the macrolide class of antibiotics. It works by inhibiting bacterial protein synthesis, thereby preventing the growth and spread of bacteria in the body. This mechanism of action makes clarithromycin effective against a wide range of Gram-positive and Gram-negative bacteria.

Clinical trials have demonstrated the efficacy of prolonged-release formulations of clarithromycin, such as Clabax OD tablets, in providing sustained therapeutic levels of the drug in the body. This sustained release profile not only enhances patient compliance by reducing the frequency of dosing but also ensures optimal drug concentrations at the site of infection, improving treatment outcomes.